The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
Open accessAbstract
The details of the mechanism by which severe acute respiratory syndrome-associated coronavirus (SARS-CoV) causes severe pneumonia are unclear. We investigated the immune responses and pathologies of SARS-CoV-infected BALB/c mice that were immunized intradermally with recombinant vaccinia virus (VV) that expressed either the SARS-CoV spike (S) protein (LC16m8rVV-S) or simultaneously all the structural proteins, including the nucleocapsid (N), membrane (M), envelope (E), and S proteins (LC16m8rVV-NMES) 7–8 wk before intranasal SARS-CoV infection. The LC16m8rVV-NMES-immunized group exhibited as severe pneumonia as the control groups, although LC16m8rVV-NMES significantly decreased the pulmonary SARS-CoV titer to the same extent as LC16m8rVV-S. To identify the cause of the exacerbated pneumonia, BALB/c mice were immunized with recombinant VV that expressed the individual structural proteins of SARS-CoV (LC16mOrVV-N, -M, -E, -S) with or without LC16mOrVV-S (i.e., LC16mOrVV-N, LC16mOrVV-M, LC16mOrVV-E, or LC16mOrVV-S alone or LC16mOrVV-N + LC16mOrVV-S, LC16mOrVV-M + LC16mOrVV-S, or LC16mOrVV-E + LC16mOrVV-S), and infected with SARS-CoV more than 4 wk later. Both LC16mOrVV-N-immunized mice and LC16mOrVV-N + LC16mOrVV-S-immunized mice exhibited severe pneumonia. Furthermore, LC16mOrVV-N-immunized mice upon infection exhibited significant up-regulation of both Th1 (IFN-γ, IL-2) and Th2 (IL-4, IL-5) cytokines and down-regulation of anti-inflammatory cytokines (IL-10, TGF-β), resulting in robust infiltration of neutrophils, eosinophils, and lymphocytes into the lung, as well as thickening of the alveolar epithelium. These results suggest that an excessive host immune response against the nucleocapsid protein of SARS-CoV is involved in severe pneumonia caused by SARS-CoV infection. These findings increase our understanding of the pathogenesis of SARS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676
(1968) · Medical Entomology and Zoology · Cited by 4,924
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,344
Coronavirus as a possible cause of severe acute respiratory syndrome
Peiris, J., Lai, S., Poon, L., Guan, Y., Yam, L., Lim, W., Nicholls, J., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,915
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Rota, P. A., Oberste, M. S., Monroe, S. S., Nix, W. A., Campagnoli, R., Icenogle, J. P., Peñaranda, S., Bankamp, B., Maher, K., Chen, M.-H., et al. (2003) · Science · doi:10.1126/science.1085952 · Cited by 2,474
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
WONG, C. K., LAM, C. W. K., WU, A. K. L., IP, W. K., LEE, N. L. S., CHAN, I. H. S., LIT, L. C. W., HUI, D. S. C., CHAN, M. H. M., CHUNG, S. S. C., et al. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02415.x · Cited by 1,274
Lung pathology of fatal severe acute respiratory syndrome
Nicholls, J. M., Poon, L. L., Lee, K. C., Ng, W. F., Lai, S. T., Leung, C. Y., Chu, C. M., Hui, P. K., Mak, K. L., Lim, W., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13413-7 · Cited by 1,076
The clinical pathology of severe acute respiratory syndrome (SARS): a report from China
Ding, Y., Wang, H., Shen, H., Li, Z., Geng, J., Han, H., Cai, J., Li, X., Kang, W., Weng, D., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1440 · Cited by 765
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
Yang, Z.-Y., Kong, W.-P., Huang, Y., Roberts, A., Murphy, B. R., Subbarao, K., & Nabel, G. J. (2004) · Nature · doi:10.1038/nature02463 · Cited by 665
Thai, H. T. C., Le, M. Q., Vuong, C. D., Parida, M., Minekawa, H., Notomi, T., Hasebe, F., & Morita, K. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.1956-1961.2004 · Cited by 422
Self-citationBisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 420
Franks, T. J., Chong, P. Y., Chui, P., Galvin, J. R., Lourens, R. M., Reid, A. H., Selbs, E., Mcevoy, C. P. L., Hayden, C. D. L., Fukuoka, J., et al. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00367-8 · Cited by 415
Subbarao, K., McAuliffe, J., Vogel, L., Fahle, G., Fischer, S., Tatti, K., Packard, M., Shieh, W.-J., Zaki, S., & Murphy, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3572-3577.2004 · Cited by 406
Buchholz, U. J., Bukreyev, A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403492101 · Cited by 385
He, L., Ding, Y., Zhang, Q., Che, X., He, Y., Shen, H., Wang, H., Li, Z., Zhao, L., Geng, J., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2067 · Cited by 366
Weingartl, H., Czub, M., Czub, S., Neufeld, J., Marszal, P., Gren, J., Smith, G., Jones, S., Proulx, R., Deschambault, Y., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12672-12676.2004 · Cited by 344
Glass, W. G., Subbarao, K., Murphy, B., & Murphy, P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4030 · Cited by 340
Characterization of Cytokine/Chemokine Profiles of Severe Acute Respiratory Syndrome
Jiang, Y., Xu, J., Zhou, C., Wu, Z., Zhong, S., Liu, J., Luo, W., Chen, T., Qin, Q., & Deng, P. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-857oc · Cited by 323
Severe Acute Respiratory Syndrome Coronavirus Infection of Golden Syrian Hamsters
Roberts, A., Vogel, L., Guarner, J., Hayes, N., Murphy, B., Zaki, S., & Subbarao, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.503-511.2005 · Cited by 285
Deming, D., Sheahan, T., Heise, M., Yount, B., Davis, N., Sims, A., Suthar, M., Harkema, J., Whitmore, A., Pickles, R., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030525 · Cited by 275
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
ter Meulen, J., Bakker, A. B., van den Brink, E. N., Weverling, G. J., Martina, B. E., Haagmans, B. L., Kuiken, T., de Kruif, J., Preiser, W., Spaan, W., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16506-9 · Cited by 265
The Interrelated Roles of TGF-β and IL-10 in the Regulation of Experimental Colitis
Fuss, I. J., Boirivant, M., Lacy, B., & Strober, W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.2.900 · Cited by 260
Bukreyev, A., Lamirande, E. W., Buchholz, U. J., Vogel, L. N., Elkins, W. R., Claire, M. S., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16501-x · Cited by 256
Immune Enhancement of Viral Infection
Halstead, S. B. (2015) · Chemical Immunology and Allergy · doi:10.1159/000406537 · Cited by 206
Hsieh, P.-K., Chang, S. C., Huang, C.-C., Lee, T.-T., Hsiao, C.-W., Kou, Y.-H., Chen, I.-Y., Chang, C.-K., Huang, T.-H., & Chang, M.-F. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13848-13855.2005 · Cited by 200
Roberts, A., Paddock, C., Vogel, L., Butler, E., Zaki, S., & Subbarao, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.9.5833-5838.2005 · Cited by 198
Johnson, T. R., Johnson, J. E., Roberts, S. R., Wertz, G. W., Parker, R. A., & Graham, B. S. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2871-2880.1998 · Cited by 189
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
CZUB, M., WEINGARTL, H., CZUB, S., HE, R., & CAO, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.033 · Cited by 180
Kim, T. W., Lee, J. H., Hung, C.-F., Peng, S., Roden, R., Wang, M.-C., Viscidi, R., Tsai, Y.-C., He, L., Chen, P.-J., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4638-4645.2004 · Cited by 173
Che, X., Qiu, L., Liao, Z., Wang, Y., Wen, K., Pan, Y., Hao, W., Mei, Y., Cheng, V. C. C., & Yuen, K. (2005) · The Journal of Infectious Diseases · doi:10.1086/430355 · Cited by 165
Kapadia, S. U., Rose, J. K., Lamirande, E. W., Vogel, L., Subbarao, K., & Roberts, A. (2005) · Virology · doi:10.1016/j.virol.2005.06.016 · Cited by 155
Zhang, X., Wu, K., Wang, D., Yue, X., Song, D., Zhu, Y., & Wu, J. (2007) · Virology · doi:10.1016/j.virol.2007.04.009 · Cited by 141 · cited 1×
“(45) reported recently the molecular mechanism of IL-6 expression induction by the N protein of SARS-CoV.”
Du, L., Zhao, G., Lin, Y., Sui, H., Chan, C. C. S., Ma, S., He, Y., Jiang, S., Wu, C. Y., Yuen, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.948 · Cited by 137
Cimolai, N., Taylor, G. P., Mah, D. G., & Morrison, B. J. (1992) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1992.tb02045.x · Cited by 132
Huang, Y., Yang, Z., Kong, W., & Nabel, G. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12557-12565.2004 · Cited by 132
Corapi, W. V., Olsen, C. W., & Scott, F. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6695-6705.1992 · Cited by 129
Macaque Model for Severe Acute Respiratory Syndrome
Rowe, T., Gao, G., Hogan, R. J., Crystal, R. G., Voss, T. G., Grant, R. L., Bell, P. L., Kobinger, G., Wivel, N. A., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11401-11404.2004 · Cited by 122
Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates
Liu, S., Leng, C. H., Lien, S., Chi, H.-Y., HUANG, C., LIN, C., Wu, L., Chen, C., HSIEH, S., & Chong, P. C.-S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.01.058 · Cited by 120
Assembly of human severe acute respiratory syndrome coronavirus-like particles
Ho, Y.-H., Lin, P.-H., Liu, C. Y. Y., Lee, S.-P., & Chao, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.111 · Cited by 117
Bisht, H., Roberts, A., Vogel, L., Subbarao, K., & Moss, B. (2005) · Virology · doi:10.1016/j.virol.2005.01.042 · Cited by 109
Induction of SARS-nucleoprotein-specific immune response by use of DNA vaccine
Zhu, M. (2004) · Immunology Letters · doi:10.1016/j.imlet.2004.01.001 · Cited by 95
Boelen, A., Andeweg, A. C., Kwakkel, J., Lokhorst, W., Bestebroer, T. M., Dormans, J. A. M. A., & Kimman, T. G. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00213-9 · Cited by 89
Faber, M., Lamirande, E. W., Roberts, A., Papaneri, A. B., Koprowski, H., Dietzschold, B., & Schnell, M. J. (2005) · Journal of General Virology · doi:10.1099/vir.0.80844-0 · Cited by 87
Jones, B. M., Ma, E. S. K., Peiris, M. J. S., Wong, P. C., Ho, J., Lam, B., Lai, K. N., & TSANG, K. W. T. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2003.02391.x · Cited by 70
Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice
Jin, H., Xiao, C., Chen, Z., Kang, Y., Ma, Y., Zhu, K., Xie, Q., Tu, Y.-X., Yu, Y., & Wang, B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.048 · Cited by 69
Shi, S., PENG, J., Li, Y., Qin, C., LIANG, G., Xu, L., Yang, Y., Wang, J., & Sun, Q. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.11.005 · Cited by 41
Characterization of severe acute respiratory syndrome coronavirus membrane protein
Voß, D., Kern, A., Traggiai, E., Eickmann, M., Stadler, K., Lanzavecchia, A., & Becker, S. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.026 · Cited by 40
Kitabatake, M., Inoue, S., Yasui, F., Yokochi, S., Arai, M., Morita, K., Shida, H., Kidokoro, M., Murai, F., Le, M. Q., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.08.039 · Cited by 24
Self-citationCross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11
Cheng, M. W., Chan, C. W. L., Cheung, R. C. F., Bikkavilli, R. K., Zhao, Q., Au, S. W. N., Chan, P. K. S., Lee, S. S. T., Cheng, G. Y.-M., Ho, W. K. K., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.088 · Cited by 23
[Study on the dynamics of IgG antibody in 311 patients with severe acute respiratory syndrome].
Fan, B., Xie, L., Chen, L., et al. (2005) · PubMed · Cited by 2
Cited by
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Coronavirus infections and immune responses
Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., Pan, P., Wang, W., Hu, D., Liu, X., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25685 · Cited by 1,946
Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
Sadoff, J., Le Gars, M., Shukarev, G., Heerwegh, D., Truyers, C., de Groot, A. M., Stoop, J., Tete, S., Van Damme, W., Leroux-Roels, I., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034201 · Cited by 1,208
Viral targets for vaccines against COVID-19
Dai, L., & Gao, G. F. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00480-0 · Cited by 1,048
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
van Doremalen, N., Lambe, T., Spencer, A., Belij-Rammerstorfer, S., Purushotham, J. N., Port, J. R., Avanzato, V. A., Bushmaker, T., Flaxman, A., Ulaszewska, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2608-y · Cited by 914
Metadata
- Authors
- Yasui, F., Kai, C., Kitabatake, M., Inoue, S., Yoneda, M., Yokochi, S., Kase, R., Sekiguchi, S., Morita, K., Hishima, T., Suzuki, H., Karamatsu, K., Yasutomi, Y., Shida, H., Kidokoro, M., Mizuno, K., Matsushima, K., & Kohara, M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-11-01
- Volume
- 181
- Issue
- 9
- Pages
- 6337-6348
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2102619382
- Cited by
- 252
- References
- 52
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.